Below are the financial statements of Cochlear, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of AUD | 2025 | 2024 |
|---|---|---|
| Revenue | 2,343.1a | 2,235.6a |
| Cost of sales | -615.2a | -562.1a |
| Gross profit | 1,727.9a | 1,673.5a |
| Selling, marketing and general expenses | -732a | -685a |
| Research and development expenses | -291.5a | -277a |
| Administration expenses | -207.9a | -212.6a |
| Other income | 26.4a | 11a |
| Other expenses | -4.2a | -34.3a |
| Share of losses on equity-accounted investments | -0.9a | -0.6a |
| Results from operating activities | 517.8a | 475a |
| Finance income - interest | 11.7a | 19a |
| Finance expense - interest | -11a | -9.2a |
| Net finance income | 0.7a | 9.8a |
| Profit before income tax | 518.5a | 484.8a |
| Income tax expense | -129.6a | -128a |
| Net profit | 388.9a | 356.8a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.